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Background: Aortic aneurysms are common vascular conditions that cause considerable morbidity and mortality.
Understanding of the mechanisms involved in the pathogenesis of the condition remains limited. Recently, infection has
been suggested as possible contributor in the development of the disease. The aim of the present study was to examine
aortic aneurysms for the presence of bacterial DNA using polymerase chain reaction (PCR) targeting the 16S ribosomal
RNA (rRNA) gene, followed by cloning and sequencing.
Methods: Universal eubacterial primers were used to amplify 16S rRNA bacterial genes in 10 specimens from arterial walls
of aortic aneurysms. Subsequently, PCR amplicons were cloned into Escherichia coli and sequencing of the cloned inserts
was used to determine species identity or closest relatives by comparison with known sequences in GenBank.
Results: Sequences of Stenotrophomonas spp., including S. maltophilia (formerly Pseudomonas homology group V) were
detected in six aneurysm samples. Propionibacterium acnes was identified in five samples, and Brevundimonas diminuta
(formerly P. diminuta) in four samples. Other species previously assigned to the Pseudomonas genus such as Comamonas
testosteroni, Delftia acidovorans, Burkholderia cepacia, Herbaspirillum sp., and Acidovorax sp. were also detected. Some
clones fell into other environmental species, including Methylobacterium sp. and Bradyrhizobium elkanii, and others
represented bacteria that have not yet been cultivated. DNA sequences from oral bacteria, including Streptococcus
sanguinis, Tannerella forsythia, and Leptotrichia buccalis were detected. Sequences from Prevotella melaninogenica and
Lactobacillus delbrueckii, which are commonly found in both mouth and gastrointestinal tract, were also detected.
Additional species included Dermacoccus spp. and Corynebacterium vitaeruminis.
Conclusions:A wide variety of bacteria, including oral bacteria, was found to colonize aortic aneurysms and may play a role
in their development. Several of these microorganisms have not yet been cultivated. (J Vasc Surg 2006;44:1055-60.)
Clinical Relevance: Although Chlamydophila pneumoniae has been detected in aneurysmal walls, its exact role in the
condition remains inconclusive. Overall, there is scarce information about the role of microorganisms in aneurysmal
disease. In the present study, we used molecular genetics to detect a diversity of bacteria in arterial walls of aortic
aneurysms. The presence of multiple microorganisms in aneurysmal disease may have implications for chemoprophylaxis
and antibiotic treatment if directed only at C. pneumoniae.Aortic aneurysms are life-threatening conditions asso-
ciated with significant morbidity and mortality. The hall-
marks in the pathogenesis of aortic aneurysms are destruc-
tion of elastin and collagen combined with medial and
adventitial inflammation, and their etiology is complex and
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the disease are yet not fully understood.1
Recently, infection has been proposed as a contributing
factor in the development of the disease. So far, most
experimental and clinical studies examining aortic aneu-
rysms have focused on a possible etiologic role of chronic
infection with Chlamydophila (formerly Chlamydia) pneu-
moniae.2 Little is known about the role of other microor-
ganisms in the development and progression of aneurysms.
If infection does play a causal role, it would seem highly
likely that various and multiple pathogens are causally
involved and that hematogenous spreading may be likely.
Although culture-based methods may be useful to
identify possible pathogens, they usually do not enable
prediction of the associated clinical burden, because less
numerous or difficult-to-cultivate species may not be de-
tected. Advances in molecular biology in the last decade
have permitted the study of microbial communities based
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reaction (PCR) amplification of the bacterial 16S ribosomal
RNA (rRNA) gene, followed by cloning and sequencing of
the inserts, have resulted in improved information of bac-
terial diversity from clinical and environmental samples.3
The 16S rRNA molecule is a basic constituent of the
bacterial ribosome, which is a highly conserved structure
with an important function in protein synthesis. The rRNA
molecules contain several functionally different regions,
some of which have highly conserved sequences, and others
have regions of highly variable sequence.4 By designing
PCR primers complementary to conserved regions of the
rRNA gene, the approach may be useful in identifying
fastidious, uncultivable, and novel microorganisms.5,6 Af-
ter cloning and sequencing of the PCR products, the 16S
rRNA sequences are compared with other known 16S
rRNA sequences to establish phylogenetic affinities and
place the organism of interest within a phylogenetic tree.4
The purpose of the present study was to examine the
presence of bacterial DNA in aortic aneurysms by using
PCR technique targeting the 16S rRNA gene, followed by
cloning and sequencing.
METHODS
Patients and specimens. Specimens from arterial walls
of 56 consecutive aortic aneurysm samples were examined
for bacterial DNA and DNA of putative periodontal patho-
gens using the PCR technique as described in a previous
study.7 A set of universal primers was used to examine the
presence of bacterial DNA, and 50 (89.2%) of the 56
samples were positive. In the present study, 10 aneurysm
specimens from nine patients were randomly selected from
the 50 PCR-positive specimens to investigate bacterial spe-
cies present in aortic aneurysms by means of cloning and
16S rDNA sequencing analysis. The characteristics of the
patients are summarized in the Table. Informed consent
was obtained from the patients, and the study was approved
by the Regional Committee on Medical Ethics.
DNA preparation from the tissue samples. The tis-
sue samples (approximately 25 mg) were homogenized in a
sterile mortar with liquid nitrogen in a laminar flow hood,
under strict aseptic conditions. Before homogenization,
the aortic specimens were washed with sterile TE buffer to
ensure no contamination with blood-borne bacteria.
DNA was extracted as previously described 7 using a
commercial kit (QIAamp Mini Kit, Qiagen GmbH,
Hilden, Germany) according to themanufacturer’s instruc-
tions. Control extraction samples containing sterile dis-
tilled water (Ultrapure quality, PCR-grade, Qiagen) in-
stead of tissue samples were run in parallel in order to check
the sterility of the solutions and buffers used in the DNA
extraction method.
PCR amplification of 16S rDNA and purification of
PCR products. Amplification of 16S rDNA occurred un-
der standardized conditions using previously published
universal eubacterial primers.8 The primers used were PA
5=-AGA GTT TGA TCC TGG CTC AG-3= and PD 5=-
GTA TTA CCG CGG CTG CTG-3=. PCR was performedin thin-walled tubes using the GeneAmp PCR System 2700
(Applied Biosystems, Foster City, Calif), with a master mix
solution (HotStarTaq Master Mix, Qiagen GmbH) con-
taining 2.5 units of Taq DNA polymerase, 1 PCR buffer
with 1.5 mM MgCl2, 200 M of each deoxynucleoside
triphosphates, 0.2Mof primer PA, 0.2Mof primer PD,
and 10 L of the template DNA, in a total volume of
50 L.
In a hot start protocol, samples were denatured at 95°C
for 15 minutes, followed by amplification consisting of a
denaturation step at 95°C for 40 seconds, annealing at
58°C for 1 minute, and elongation at 72°C for 1 minute. A
total of 32 cycles was performed, followed by a final elon-
gation step at 72°C for 10 minutes.
Each set of experiments included negative controls
with sterile distilled water instead of template DNA and
positive controls containing purified DNA from Escherichia
coli. The results of PCR amplification were examined by
electrophoresis in a 1% agarose gel. DNAwas visualized and
photographed under ultraviolet light after ethidium bro-
mide staining (Fig 1). Before cloning, amplicons were
purified using the QIAquick Gel Extraction Kit (Qiagen)
according to the manufacturer’s instructions.
Cloning and 16S rDNA sequencing. The amplicons
were ligated into the pCR4-TOPO vector (Invitrogen,
Carlsbad, Calif) and transformed into competent E. coli
TOP10 cells (Invitrogen) according to instructions of the
manufacturer. The transformed cells were then plated onto
Luria-Bertani agar plates supplemented with kanamycin
(50 g/mL), and incubated overnight at 37°C. Ninety-six
colonies containing the insert were then placed into 40 L
of 10mMTris. Correct sizes of the inserts were determined
by PCR with an M13 (-20) forward primer and an M13
reverse primer (Invitrogen), followed by electrophoresis on
a 1% agarose gel.
PCR products were purified by adding 1 L of shrimp
alkaline phosphatase and 1 L of exonuclease I to 7 L of
the PCR product according to the manufacturer’s instruc-
tions (Amersham Pharmacia Biotech, Oslo, Norway).
Purified DNAwas sequenced on both strands using the
ABI Prism BigDye Terminator Cycle Sequencing Ready
Reaction kit with AmpliTaq DNA polymerase FS (Applied
Biosystems). The primers PB and PC (PB 5=-TAA CAC
ATG CAA GTC GAA CG-3= and PC 5’- CCC ACT GCT
GCC TCC CGT AG-3=) were used for sequencing.8 Se-
quencing reactions were run on an ABI Prism 3100 DNA
sequencer (Applied Biosystems).
Data analyses of 16S rDNA sequences. DNA se-
quences were assembled with the SEQUENCHER 4.0.5
program (Gene Codes Corp, Ann Arbor, Mich) and ana-
lyzed for the presence of chimeric sequences using the
Chimera Check program from the Ribosomal Database
Project II.9 After elimination of suspected chimeric se-
quences, the partial 16S rDNA sequences of approximately
500 bp were used to determine identity or nearest phylo-
genetic position. For identification of closest relatives, the
consensus sequences were compared with 16S rDNA se-
quences in GenBank databases using the NCBI BLAST
cedure
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The sequences were aligned by the ClustalV (Higgins and
Sharp, 1988 and 1989) method, with aligned fragments
corresponding to E. coli nucleotide positions 50-361.8
Phylogenetic trees were constructed using the MegAlign
program (DNASTAR, Inc, Madison, Wisc).
RESULTS
Sequencing was used to analyze 83 clones. All 16S
Table. Characteristic features of patients’ aneurysm sampl
reaction, cloning and 16S rDNA sequencing and their Gen
Subject Age/Sex Location in aorta Etiology/associated con
Ac 39/M Ascendingc Congenital/Marfan’s
syndrome
Bd 32/M Ascending, arch Mechanical/CoA
C 43/M Ascending Mechanical
D 73/M Ascending Mechanical
E 22/F Descending Inflammatory
F 67/F Ascending Degenerative/atherosc
Ge 70/F Descendinge Degenerative/atherosc
H 75/F Abdominal Degenerative/atherosc
I 77/F Abdominal Degenerative/atherosc
Jd 32/M Descending Postoperative/previou
CoA, Aortic coarctation.
aThe number of clones is given in parenthesis (for each sample if 1).
bAccession number of the nearest 16S rDNA sequences is given for each strai
for values 98%.
cPatient previously operated in the same location.
dB and J refer to the same subject operated in two locations in separate pro
ePatient previously operated in a different location with concomitant coronrDNA sequences, except for two (uncultured clostridiabacterium and uncultured Weissella sp), showed 98%
similarity to sequences deposited to GenBank (Table). The
detected 16S rDNA sequences were represented by two
major clusters at 10% nucleotide difference (Fig 2). All but
one specimen harbored several bacterial species. The 10
analyzed clones from patient C were all identical, showing
92% identity to an uncultured Weissella sp. (Lactobacillus-
like organism). The sample from patient I was the most
heterogeneous, with 10 different bacterial species identified
d bacteria detected analyzed by polymerase chain
k accession numbers
Bacteriaa
GenBank accession
numbersb
Comamonas testosteroni
Herbaspirillum sp.
Uncultured clostridia bacterium
Leptotrichia buccalis (2)
Tannerella forsythia (2)
AY653219
AY953141
AY607222 [96%]
L37788
AB053940
B-proteobacterium B6
-proteobacterium MBIC3025
Propionibacterium acnes (7)
AF035052
AB016980
AY458863
Uncultured Weissella sp. (10) AY421855 [92%]
Methylobacterium sp (5)
Brevundimonas diminuta (2)
AY468371
AY730717
Stenotrophomonas sp. JRL-2
Methylobacterium sp. (3)
Brevundimonas diminuta (2)
Bradyrhizobium elkanii (2)
Lactobacillus delbrueckii ss bulgaricus
Propionibacterium acnes
AF181569
AY468371
AY730717
AY568513
AY568513
AY458863
is Stenotrophomonas sp. dune 276
S. maltophilia SM14U
Dermacoccus sp. Ellin183 (3)
Propionibacterium acnes (5)
AJ884482
AF533952
AF409025
AY458863
is Stenotrophomonas sp. dune 276
Methylobacterium sp.
Uncultured Bradyrhizobium
AJ884482
AY468371
AY437440
is Stenotrophomonas maltophilia SM14U
Propionibacterium acnes (4)
Streptococcus sanguinis (2)
Dermacoccus sp. Ellin183 (2)
AF533952
AY458863
AF543281
AF409025
is Delftia acidovorans (2)
Acidovorax sp.
Burkholderia cepacia (2)
Stenotrophomonas sp. JRL-2
S. maltophilia E2
Brevundimonas diminuta
Dermacoccus sp. L560
Corynebacterium vitarumen
Propionibacterium acnes
Prevotella melaninogenica (2)
Uncultured Bacteroidetes bacterium
AY178541
AJ012071
AY268149
AF181569
AY841799
AY730717
AY367751
X84680
AY458863
L16469
DQ06661
Stenotrophomonas sp. JRL-2
Uncultured bacterium 227ds5
S maltophilia SM14U
Dermacoccus sp. Ellin183
AF181569
AY212674
AF533952
AF409025
centage of 16S rDNA sequence similarity is indicated in brackets, given only
s.
ery bypass surgery.es an
Ban
dition
leros
leros
leros
leros
s CoA
n. Peramong the 16 clones sequenced. DNA of Stenotrophomonas
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mology group V) was detected in six aneurysm samples.
Propionibacterium acnes DNA was identified in five speci-
mens, and Brevundimonas diminuta (formerly classified as
a member of the group IV of the genus Pseudomonas) was
found in four specimens. Other species previously assigned
to the Pseudomonas genus, such as Comamonas testosteroni,
Delftia acidovorans, Burkholderia cepacia, Herbaspirillum
sp. and Acidovorax sp. were also detected. Some clones fell
into other environmental species, such as Methylobacte-
rium sp. and Bradyrhizobium elkanii, and others repre-
sented not-yet-cultivable bacteria (cluster I). Additional
species found in this cluster includedDermacoccus spp. and
Corynebacterium vitaeruminis.
DNA from a putative periodontal pathogen, Tan-
nerella forsythia, was detected in one sample (A). DNA
corresponding to other oral bacteria, including Streptococ-
cus sanguinis and Leptotrichia buccaliswere detected. DNA
of Prevotella melaninogenica and Lactobacillus delbrueckii
subsp. bulgaricus, which are commonly found in both
mouth and gastrointestinal tract, was also detected in one
patient each (cluster II).
DISCUSSION
The main finding in this study was the presence of
bacterial DNA from a diversity of species in aortic aneu-
rysms of different clinical etiologies. Moreover, most spec-
imens contained multiple species, pointing to a less specific
relationship between single species and the development of
inflammation in the aortic wall as well as subsequent pro-
gression to aneurysmal disease. This agrees with our previ-
ous demonstration of multiple bacteria on the walls of
aortic aneurysms by means of electron microscopy and
anaerobic cultivation.10 Coaggregating and dividing bacte-
rial cells inside tissue with different morphologies were
observed, often organized in biofilm structures. Some of
the bacteria identified in our study cannot yet be cultured.
Because a great part of human microflora still is estimated
to resist cultivation,11,12 it is conceivable that aortic aneu-
rysms also harbor uncultivable species, as demonstrated
here. Taken together, these findings suggested that aortic
aneurysms contain a much more diverse bacterial burden
Fig 1. Polymerase chain reaction products from aortic aneurysm
samples using eubacterial primers to amplify approximately 500 bp
of the 16S rRNA gene. Lane M, Molecular weight marker (1Kb
DNA Ladder, Invitrogen). Lanes 1 to 10, DNA extracted from
patients’ aneurysm samples. Lanes N, negative controls (sterile
water). Lane P, positive control (purified DNA from E. coli).than previously estimated.To our knowledge, our findings in aortic aneurysms
are original. Therefore, questions about sampling and
methodology must be raised. It should be emphasized
that strict aseptic conditions were imposed to avoid
contamination both during surgery and in the labora-
tory. However, biologic material from control samples
was not included in our study. Instead, control extrac-
tion samples with sterile water were used to test the
sterility of solutions and buffers used during DNA prep-
aration, which gave negative results.7 In addition, no
amplification of bacterial DNA was seen in the PCR
experiments using sterile water instead of template
DNA, which also argued against contamination of the
PCR reagents (Fig 1). It is also unlikely that DNA
sequences detected from oral bacteria, including obli-
gate anaerobes, such as T. forsythia, P. melaninogenica
and L. buccalis, could have been introduced during
sample preparation.
Most of the bacteria detected in the present study,
including the many environmental species, have been re-
ported as either opportunists or true pathogens in different
human diseases. B. cepacia, for instance, is known as a
typical pathogen in patients with cystic fibrosis.13 Other
organisms detected, including C testosteroni and Herbaspi-
rillum sp., have also been identified from cystic fibrosis spu-
tum by fatty acids analysis and 16S rDNA sequencing.14 B
diminuta, which was formerly classified as a member of
Pseudomonas group IV (P. diminuta) has been isolated from
clinical samples, particularly from blood in cancer pa-
tients.15,16 Another example is S. maltophilia, which has
recently emerged as an important multidrug-resistant
nosocomial pathogen associated with significant mortal-
ity, especially in immunocompromised patients. S. mal-
tophilia is now the second most frequently isolated nos-
ocomial bacterium after Pseudomonas aeruginosa.17
The spectrum of the infections includes pneumonia,
urinary and wound infections, infections in cystic fibrosis
patients, bacteremia, and endocarditis.13,18,19 Infective en-
docarditis of a prosthetic aortic valve associated with a
dissecting aneurysm of the ascending aorta due to S. mal-
tophilia has been reported.20 Of interest is a recent stud y b y
Ott et al21 who, using the same methodology, have
reported a very similar bacterial composition and a broad
variety of bacteria in atherosclerotic tissue obtained
through atherectomy of patients with coronary heart
disease, clearly supporting our findings. Therefore, the
presence of these organisms in aortic aneurysms should
not be considered as contamination.
P. acnes, which was detected in 50% of the specimens,
can clearly act as a primary pathogen. The organism has
previously been isolated from soft tissue abscesses, endo-
carditis, prosthetic hip infections, patients with sarcoidosis,
and also from mycotic aortic aneurysms.22-28 Endocarditis
caused by P. acnes may follow a very aggressive course,
especially in the setting of a prosthetic valve.28
Another interesting finding was the sole detection of
sequences related to an uncultured Weissella sp. in subject
C (Table). The genus Weissella is proposed to accommo-
e.
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usual interpeptide bridges in the peptidoglycan. Weissella
spp. are food-associated lactic acid bacteria, but are also
associated with spoilage of refrigerated meat products.29,30
Like other Lactobacillus spp., these organisms can cause
low-grade infections, bacteremia, and endocarditis.31,32
They may be present in patients with complex medical
history or in patients receiving multiple antibiotics over
time.31
The presence of bacteria shown both by culture in a
previous study,10 and by PCR in this study, creates
speculation about the original source of these organisms
detected in the vessel wall. Although direct tissue inva-
sion and lymphatic spread might be possible, the hema-
togenous route seems most likely. Hematogenous
spreading is also supported by the detection of DNA
from oral bacteria in the present study. Bacterial trans-
location during surgical and dental procedures, oral
infections, and even chewing and toothbrushing are
generally known to cause transient bacteremia.33 Blood-
borne microorganisms are usually cleared by the immune
system within minutes. However, if the disseminated
oral microorganisms find favorable conditions, they may
colonize a given site, as has been well documented in
Fig 2. Phylogenetic tree of representative 16S rDNA
sequences were aligned using ClustalV, and the unrooted
two major clusters at 10% nucleotide sequence differenccases of infective endocarditis.34CONCLUSION
The presence of bacteria in aortic aneurysms did not
necessarily imply a causal relationship in aneurysm initiation
and development, and some of these bacteria might have
been secondary colonizers of a previously damaged vessel.
The bacteria were detected regardless of etiology and ana-
tomic location of the aneurysms, and even nonarterioscle-
rotic aneurysms contained microorganisms. It could be
speculated that disorders of the connective tissue (eg, in
Marfan’s syndrome) and other underlying and predispos-
ing conditions, such as turbulent blood flow or nonbacte-
rial inflammation, may facilitate penetration and secondary
colonization of microorganisms in the walls of aortic aneu-
rysms. However, molecular detection of multiple bacteria
in the walls of aortic aneurysms strongly suggested that
these bacteria might have been important contributors
to the inflammatory reaction during aneurysm forma-
tion, and therefore, may play a role in the development
of the aneurysms.
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